CUE
Cue Biopharma Inc · NASDAQ NMS - GLOBAL MARKET · Biotechnology
$0.19+$0.01 (+6.33%)
Prices delayed up to 5 minutes
AC Intelligence
AC Intelligence
AC Intelligence for CUE is being prepared.
Key Stats
Key Stats
Open
$0.21
Day High
$0.23
Day Low
$0.17
Prev Close
$0.18
Volume
0
Avg Volume
1.0M
Day Change
+$0.01
Change %
+6.33%
Fundamentals
Fundamentals
P/B
1.05
EPS (TTM)
$-0.31
Market Cap
$17M
52-Wk Range
$0.17 — $1.03
Earnings History
Insider Activity
Who Owns This Stock
Who Owns CUE
Other77.1%35 holders
Passive / Index19.6%3 holders
Dealer / Bank1.8%8 holders
Systematic / Quant1.1%1 holder
Based on Q4 2025 13F filings + AC behavioral model
48 institutional holders
Top Holders
$2082.6B
+35.0%$1414.5B
-90.1%$782.7B
-1.3%$749.5B
$672.8B
$215.1B
+398.4%$202.7B
-78.2%$165.8B
0.0%$146.1B
$136.4B
+158.3%$94.7B
0.0%$78.6B
+25.4%$75.3B
+5.0%$72.8B
-36.1%$63.3B
$54.8B
$45.5B
+4.9%$42.7B
0.0%$32.7B
Institutional Pressure
Market Regime:Strong Risk-Off (-0.62)SELLINGBUYING
▲
Mild Selling Pressure
Other(77.1%)
●
—Passive / Index(19.6%)
●
HoldsDealer / Bank(1.8%)
●
FacilitatingSystematic / Quant(1.1%)
●
De-risking (mechanical)Income / Defensive(0.4%)
●
Inflows (flight to yield)20% passive + quality floor won't sell.
Updated daily · Based on Q4 2025 filings + AC behavioral model
Sentiment Signals
Sentiment Signals
→Insider ActivityNo insider transactions in last 90 daysSEC Form 4
↑Analyst Consensus4 buy, 1 hold, 0 sellFinnhub
↑↑Inst. Flows33 increased/new, 13 decreased/exited (13F)AC 13F Analysis
Sources: SEC Form 4, Finnhub, AC 13F Analysis
On AcidCapitalist
Data provided by Finnhub. Prices delayed up to 5 minutes.